Floatz logo

Alprazolam

Epilepsy

UCB Biopharma SRLSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
73/ 100

Competitive context

77 Active assets in the Epilepsy cohort.

Asset / SponsorPhaseRating
Topamax
SK Life Science, Inc.
Phase 4BBB
Keppra
Beijing Tiantan Hospital
Phase 4BBB
LAMOTRIGINE
Assiut University
Phase 4BBB
Topamax
Université de Sherbrooke
Phase 4BBB
Eslicarbazepine Acetate
Bial - Portela C S.A.
Phase 4BBB

View all 50 →

Same molecule, other indications

Alprazolam is also rated in:

anxiety disorderDormant
BB
Indicative ·
66 / 100
View asset →
physiological malfunction arising from mental factorDormant
B
Indicative ·
60 / 100
View asset →
Chronic Migraine Without Aura, IntractableDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →